What China is accomplishing in R&D “has implications for everyone playing in the R&D or innovation world,” McKinsey’s Fangning Zhang says.
In this GEN webinar, our expert speakers will explore cutting-edge drug discovery techniques for target deconvolution and multiplex target discovery.
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory in Singapore, ...
Clinical trials for drug development are notoriously slow and expensive, and only a small fraction of drug candidates end up being approved by the regulatory authorities. The extensive bottlenecks in ...
Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and ...
A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been ...
Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial ...
Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. | Excelsior Sciences, which spun out of investment ...
Excelsior Sciences cofounders say the company will make new molecules using robots and artificial intelligence ...
In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they're ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback